SCM
AGN

Stevens Capital Management’s Allergan plc AGN Stock Holding History

Stevens Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,858
Closed -$7.81M – 543
2019
Q4 		$7.81M Buy
+40,858
New +$7.37M 0.73% 29
2019
Q1 		– Sell
-26,479
Closed -$3.54M – 958
2018
Q4 		$3.54M Buy
+26,479
New +$4.34M 0.18% 168
2018
Q1 		– Sell
-145,752
Closed -$23.8M – 1082
2017
Q4 		$23.8M Buy
145,752
+123,164
+545% +$22.1M 0.93% 13
2017
Q3 		$4.63M Buy
+22,588
New +$5.25M 0.17% 167
2016
Q2 		– Sell
-13,044
Closed -$3.5M – 1206
2016
Q1 		$3.5M Hold
13,044
– – 0.14% 205
2015
Q4 		$4.08M Buy
+13,044
New +$3.88M 0.16% 181
2015
Q3 		– Sell
-3,874
Closed -$1.18M – 1312
2015
Q2 		$1.18M Sell
3,874
-52,633
-93% -$15.7M 0.04% 387
2015
Q1 		$16.8M Buy
+56,507
New +$16.1M 0.6% 39
2014
Q2 		– Sell
-5,962
Closed -$1.23M – 1396
2014
Q1 		$1.23M Buy
5,962
+2,793
+88% +$553K 0.03% 438
2013
Q4 		$532K Buy
+3,169
New +$495K 0.02% 634

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stevens Capital Management's AGN Position: Q1 2020 in Review

Stevens Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 40,858 shares — an estimated $7.81M sold.

Stevens Capital Management first reported a position in AGN in Q4 2013 and held it in 10 quarters. The position peaked at $23.8M in Q4 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Stevens Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 40,858 Allergan plc shares in Q1 2020, an estimated $7.81M.
  • Stevens Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 10 quarters.
  • Stevens Capital Management's Allergan plc position peaked at $23.8M in Q4 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.